Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 2
2012 4
2013 5
2014 9
2015 11
2016 5
2017 6
2018 5
2019 3
2020 5
2021 3
2022 9
2023 3
2024 5
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, McArthur H, Pusztai L, Kümmel S, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Im SA, Untch M, Fasching PA, Mouret-Reynier MA, Foukakis T, Ferreira M, Cardoso F, Zhou X, Karantza V, Tryfonidis K, Aktan G, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2024 Nov 28;391(21):1981-1991. doi: 10.1056/NEJMoa2409932. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282906 Clinical Trial.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651. N Engl J Med. 2022. PMID: 35139274 Clinical Trial.
Glutamatergic Modulators in Depression.
Henter ID, de Sousa RT, Zarate CA Jr. Henter ID, et al. Among authors: de sousa rt. Harv Rev Psychiatry. 2018 Nov/Dec;26(6):307-319. doi: 10.1097/HRP.0000000000000183. Harv Rev Psychiatry. 2018. PMID: 29465478 Free PMC article. Review.
Exploring new pathways in endocrine-resistant breast cancer.
de Pinho IS, Abreu C, Gomes I, Casimiro S, Pacheco TR, de Sousa RT, Costa L. de Pinho IS, et al. Among authors: de sousa rt. Explor Target Antitumor Ther. 2022;3(3):337-361. doi: 10.37349/etat.2022.00086. Epub 2022 Jun 20. Explor Target Antitumor Ther. 2022. PMID: 36045911 Free PMC article. Review.
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.
Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R. Henter ID, et al. Among authors: de sousa rt. Expert Rev Clin Pharmacol. 2017 Feb;10(2):153-166. doi: 10.1080/17512433.2017.1253472. Epub 2017 Jan 16. Expert Rev Clin Pharmacol. 2017. PMID: 27781556 Free PMC article. Review.
DNA damage targeted therapy for advanced breast cancer.
Patel V, Casimiro S, Abreu C, Barroso T, de Sousa RT, Torres S, Ribeiro LA, Nogueira-Costa G, Pais HL, Pinto C, Costa L, Costa L. Patel V, et al. Among authors: de sousa rt. Explor Target Antitumor Ther. 2024;5(3):678-698. doi: 10.37349/etat.2024.00241. Epub 2024 Jun 25. Explor Target Antitumor Ther. 2024. PMID: 38966174 Free PMC article. Review.
The RSNA Pediatric Bone Age Machine Learning Challenge.
Halabi SS, Prevedello LM, Kalpathy-Cramer J, Mamonov AB, Bilbily A, Cicero M, Pan I, Pereira LA, Sousa RT, Abdala N, Kitamura FC, Thodberg HH, Chen L, Shih G, Andriole K, Kohli MD, Erickson BJ, Flanders AE. Halabi SS, et al. Among authors: sousa rt. Radiology. 2019 Feb;290(2):498-503. doi: 10.1148/radiol.2018180736. Epub 2018 Nov 27. Radiology. 2019. PMID: 30480490 Free PMC article.
71 results